Corporate
Ironwood Surges 27% on Counter-Intuitive Move: Lower Drug Prices, Higher Net Sales
Jan 2
You're signed outSign in or to get full access.
IP
IRONWOOD PHARMACEUTICALS (IRWD)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering IRONWOOD PHARMACEUTICALS.